Barclays’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.5M | Buy |
533,416
+410,253
| +333% | +$21.9M | 0.01% | 685 |
|
2025
Q1 | $4.99M | Sell |
123,163
-9,674
| -7% | -$392K | ﹤0.01% | 1422 |
|
2024
Q4 | $3.7M | Buy |
132,837
+5,169
| +4% | +$144K | ﹤0.01% | 1813 |
|
2024
Q3 | $3.66M | Buy |
127,668
+71,652
| +128% | +$2.06M | ﹤0.01% | 1742 |
|
2024
Q2 | $1.32M | Sell |
56,016
-14,665
| -21% | -$344K | ﹤0.01% | 1961 |
|
2024
Q1 | $1.79M | Sell |
70,681
-175,593
| -71% | -$4.43M | ﹤0.01% | 2024 |
|
2023
Q4 | $5.75M | Buy |
246,274
+114,828
| +87% | +$2.68M | ﹤0.01% | 1389 |
|
2023
Q3 | $6.65M | Sell |
131,446
-11,632
| -8% | -$588K | ﹤0.01% | 1005 |
|
2023
Q2 | $6.68M | Buy |
143,078
+65,854
| +85% | +$3.07M | ﹤0.01% | 1073 |
|
2023
Q1 | $2.95M | Sell |
77,224
-26,328
| -25% | -$1.01M | ﹤0.01% | 1401 |
|
2022
Q4 | $5.67M | Buy |
103,552
+102,364
| +8,616% | +$5.61M | ﹤0.01% | 1047 |
|
2022
Q3 | $40K | Sell |
1,188
-10,890
| -90% | -$367K | ﹤0.01% | 3721 |
|
2022
Q2 | $114K | Buy |
12,078
+4,468
| +59% | +$42.2K | ﹤0.01% | 3412 |
|
2022
Q1 | $107K | Sell |
7,610
-27,820
| -79% | -$391K | ﹤0.01% | 3633 |
|
2021
Q4 | $749K | Buy |
35,430
+21,362
| +152% | +$452K | ﹤0.01% | 2346 |
|
2021
Q3 | $315K | Buy |
14,068
+8,592
| +157% | +$192K | ﹤0.01% | 2792 |
|
2021
Q2 | $136K | Sell |
5,476
-7,281
| -57% | -$181K | ﹤0.01% | 3038 |
|
2021
Q1 | $369K | Buy |
12,757
+6,819
| +115% | +$197K | ﹤0.01% | 2828 |
|
2020
Q4 | $153K | Sell |
5,938
-2,231
| -27% | -$57.5K | ﹤0.01% | 2820 |
|
2020
Q3 | $252K | Sell |
8,169
-9,230
| -53% | -$285K | ﹤0.01% | 2619 |
|
2020
Q2 | $434K | Buy |
17,399
+14,617
| +525% | +$365K | ﹤0.01% | 2398 |
|
2020
Q1 | $59K | Sell |
2,782
-2,236
| -45% | -$47.4K | ﹤0.01% | 3025 |
|
2019
Q4 | $112K | Buy |
5,018
+2,361
| +89% | +$52.7K | ﹤0.01% | 3415 |
|
2019
Q3 | $61K | Buy |
+2,657
| New | +$61K | ﹤0.01% | 3614 |
|